Image de couverture de Red Tigress

Red Tigress

Blood Heir Trilogy, Book 2

Écouter un extrait
La meilleure offre de la saison

0,99 €/mois pendant 3 mois + 15 € de crédit Audible

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible.
Profiter de l’offre
L'offre prend fin le 28 décembre 2026.
Plus d'offres

Red Tigress

De : Amélie Wen Zhao
Lu par : Emily Woo Zeller
Profiter de l’offre

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible. L'offre se termine le 28 décembre 2026.

Acheter pour 21,04 €

Acheter pour 21,04 €

La meilleure offre de la saison | 0,99 €/mois pendant les 3 premiers mois + 15 € de crédit Audible

6,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce titre

Fans of Children of Blood and Bone will love the sequel to Blood Heir. The second book in an epic fantasy series about a princess hiding a dark secret and the con man she must trust to liberate her empire from a dark reign.

Ana Mikhailov is the only surviving member of the royal family of Cyrilia. She has no army, no title, and no allies, and now she must find a way to take back the throne or risk the brutal retribution of the empress.

Morganya is determined to establish a new world order on the spilled blood of non-Affinites. Ana is certain that Morganya won't stop until she kills them all.

Ana's only chance at navigating the dangerous world of her homeland means partnering with Ramson Quicktongue again. But the cunning crime lord has schemes of his own. For Ana to find an army, they must cross the Whitewaves to the impenetrable stone forts of Bregon. Only, no one can be certain what they will find there.

A dark power has risen. Will revolution bring peace – or will it only paint the streets in more blood?

©2021 Amélie Wen Zhao (P)2021 HarperCollins Publishers Limited
Epic Fantasy Fantasy
adbl_web_anon_alc_button_suppression_t1

Continue the series

Image de couverture de Crimson Reign
Crimson Reign De : Amélie Wen Zhao
Aucune critique pour le moment